Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India-Reference-Cited by-同舟云学术

Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India

Published:2024-03-07 Issue:4 Volume:22 Page:569-582
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Dixit Jyoti,Malhotra Pankaj,Mehra Nikita,Mathew Anisha,Kumar Lalit,Singh Ashish,Gupta Nidhi,Krishnamurthy Manjunath Nookala,Roy Partha Sarathi,Kataki Amal Chandra,Gupta Sudeep,Prinja Shankar^ORCID

Funder

Department of Health Research, India

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40258-024-00877-1.pdf

Reference50 articles.

1. Palumbo K. Anderson, multiple myeloma. N Engl J Med. 2011;364:1046–60. https://doi.org/10.1056/NEJMra1011442.

2. Zweegman S, Palumbo A, Bringhen S, Sonneveld P. Age and aging in blood disorders: multiple myeloma. Haematologica. 2014;99:1133–7. https://doi.org/10.3324/haematol.2014.110296.

3. Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet. 2015;385:2197–208. https://doi.org/10.1016/S0140-6736(14)60493-1.

4. Bora K. Cancer Epidemiol. 2019;59:215-220 219.

5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. https://doi.org/10.1002/ijc.29210.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian Cohort;Indian Journal of Hematology and Blood Transfusion;2024-09-05